JP2009535334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009535334A5 JP2009535334A5 JP2009507739A JP2009507739A JP2009535334A5 JP 2009535334 A5 JP2009535334 A5 JP 2009535334A5 JP 2009507739 A JP2009507739 A JP 2009507739A JP 2009507739 A JP2009507739 A JP 2009507739A JP 2009535334 A5 JP2009535334 A5 JP 2009535334A5
- Authority
- JP
- Japan
- Prior art keywords
- triazolo
- isoquinolin
- benzo
- alkyl
- aminopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79469406P | 2006-04-25 | 2006-04-25 | |
| US60/794,694 | 2006-04-25 | ||
| PCT/US2007/009643 WO2007127138A1 (en) | 2006-04-25 | 2007-04-20 | Triazoloquinazolinone derivatives as inhibitors of checkpoint kinases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009535334A JP2009535334A (ja) | 2009-10-01 |
| JP2009535334A5 true JP2009535334A5 (cg-RX-API-DMAC7.html) | 2010-10-14 |
| JP5229221B2 JP5229221B2 (ja) | 2013-07-03 |
Family
ID=38441857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507739A Expired - Fee Related JP5229221B2 (ja) | 2006-04-25 | 2007-04-20 | チェックポイント・キナーゼのインヒビターとしてのトリアゾロキナゾリノン誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7501435B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2013212A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5229221B2 (cg-RX-API-DMAC7.html) |
| AR (1) | AR060619A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007243520B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2649811A1 (cg-RX-API-DMAC7.html) |
| DO (1) | DOP2007000082A (cg-RX-API-DMAC7.html) |
| TW (1) | TW200806670A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007127138A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7485649B2 (en) * | 2005-01-06 | 2009-02-03 | Merck & Co., Inc. | Inhibitors of checkpoint kinases |
| AU2006203963A1 (en) * | 2005-01-06 | 2006-07-13 | Merck Sharp & Dohme Corp. | Inhibitors of checkpoint kinases |
| US7550477B2 (en) | 2006-01-04 | 2009-06-23 | Merck & Co., Inc. | Inhibitors of checkpoint kinases |
| US9000027B2 (en) * | 2008-02-04 | 2015-04-07 | Dana-Farber Cancer Institute, Inc. | Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, bcl-2 and caspase-3 |
| AU2009215073A1 (en) * | 2008-02-14 | 2009-08-20 | Merck Sharp & Dohme Corp. | Inhibitors of checkpoint kinases |
| WO2010104933A1 (en) | 2009-03-11 | 2010-09-16 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
| US20140134178A1 (en) * | 2012-01-06 | 2014-05-15 | H. Lee Moffit Cancer Center And Research Institute | Phosphorylation of histones and uses thereof |
| EP3024456A4 (en) | 2013-07-26 | 2017-04-12 | Update Pharma Inc. | Combinatorial methods to improve the therapeutic benefit of bisantrene |
| TW201702218A (zh) | 2014-12-12 | 2017-01-16 | 美國杰克森實驗室 | 關於治療癌症、自體免疫疾病及神經退化性疾病之組合物及方法 |
| KR102875195B1 (ko) * | 2019-04-03 | 2025-10-22 | 케미테라스, 인크. | 티민 핵산 염기를 베이스로 하는 트리아졸로피리미딘류 및 그 제조 방법 |
| PE20220376A1 (es) | 2019-06-06 | 2022-03-16 | Hutchison Medipharma Ltd | Compuestos triciclicos y su uso |
| CN115197225B (zh) * | 2021-09-03 | 2023-04-11 | 贵州大学 | 一种五元杂环并喹唑啉酮类化合物及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1244501A (en) * | 1968-03-09 | 1971-09-02 | Aspro Nicholas Ltd | Heterocyclic amines |
| NZ287413A (en) * | 1994-05-24 | 1998-02-26 | Hoffmann La Roche | Dioxo derivatives of triazoloquinazoline, isoxazoloquinoline, pyrazoloquinoline and analogs, medicaments |
| US5677309A (en) * | 1996-03-22 | 1997-10-14 | Neurogen Corporation | 1,2,4-triazolo 4,3-c! quinazolin-3-ones and 1,2,4-triazolo 4,3-c!quinazolin-3-thiones; a new class of GABA brain receptor ligands |
| MXPA05009885A (es) * | 2003-03-14 | 2005-12-05 | Astrazeneca Ab | Nuevas triazolonas fusionadas y los usos de las mismas. |
| KR100959771B1 (ko) * | 2005-06-10 | 2010-05-28 | 머크 샤프 앤드 돔 코포레이션 | Ａｋｔ 활성의 억제제 |
| US7550477B2 (en) | 2006-01-04 | 2009-06-23 | Merck & Co., Inc. | Inhibitors of checkpoint kinases |
-
2007
- 2007-04-17 TW TW096113500A patent/TW200806670A/zh unknown
- 2007-04-20 AU AU2007243520A patent/AU2007243520B2/en not_active Ceased
- 2007-04-20 WO PCT/US2007/009643 patent/WO2007127138A1/en not_active Ceased
- 2007-04-20 AR ARP070101718A patent/AR060619A1/es not_active Application Discontinuation
- 2007-04-20 JP JP2009507739A patent/JP5229221B2/ja not_active Expired - Fee Related
- 2007-04-20 CA CA002649811A patent/CA2649811A1/en not_active Abandoned
- 2007-04-20 EP EP07755786A patent/EP2013212A1/en not_active Withdrawn
- 2007-04-24 US US11/789,288 patent/US7501435B2/en not_active Expired - Fee Related
- 2007-04-25 DO DO2007000082A patent/DOP2007000082A/es unknown